DVRd in the Treatment of Patients With Newly Diagnosed Double-hit Multiple Myeloma
Clinical trial NCT06158269 · RECRUITING
Trial details
- NCT number
- NCT06158269
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2026-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.